DR HARVEY A. RISCH, MD, PHD , PROFESSOR OF EPIDEMIOLOGY, YALE SCHOOL OF PUBLIC HEALTH
“When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective,” Risch explained. “Especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc.”
Earlier this month, a large peer-reviewed study found that hydroxychloroquine cut the mortality rate of COVID-19 by more than half and, contrary to previous claims by faulty studies, had no adverse effects on the heart.
Link goes to Newsweek article
You have been blocked